<i>N</i>-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors
作者:Naresh Sunduru、Mona Svensson、Mariateresa Cipriano、Sania Marwaha、C. David Andersson、Richard Svensson、Christopher J. Fowler、Mikael Elofsson
DOI:10.1080/14756366.2016.1265520
日期:2017.1.1
Fatty acid amide hydrolase (FAAH) is a promising target for the development of drugs to treat neurological diseases. In search of new FAAH inhibitors, we identified 2-(4-cyclohexylphenoxy)-N-(3-(oxazolo[4,5-b]pyridin-2-yl)phenyl)acetamide, 4g, with an IC50 of 2.6 µM as a chemical starting point for the development of potent FAAH inhibitors. Preliminary hit-to-lead optimisation resulted in 2-(4-phe
脂肪酸酰胺水解酶(FAAH)是开发用于治疗神经系统疾病的药物的有希望的目标。为了寻找新的FAAH抑制剂,我们确定了2g 2-(4-环己基苯氧基)-N-(3-(恶唑并[4,5-b]吡啶-2-基)苯基)乙酰胺,IC50为2.6 µM,开发有效的FAAH抑制剂的化学起点。初步的逐线优化得到2-i-(4-phenylphenoxy)-N-(3-(oxazolo [4,5-b] pyridin-2-yl)phenyl)乙酰胺4i,IC50为0.35 µM。